Novartis Korea launches fund-raising campaign for CML patients

Published: 2006-10-13 06:56:00

Updated: 2006-10-13 06:56:00

Novartis Korea said it has launched a campaign for the fund-raising to support Korean patients with chronic myeloid leukemia (CML) and metastatic gastrointestinal stromal tumors (GIST) as part of its plan to commemorate its successful five-year landing of Glivec in Korea.

The company has already started a campaign titled Glivec 295 Hope Storyand will distribute 295 hope saving box to medical...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.